Suzhou Zelgen Biopharmaceuticals Co Ltd - ESG Rating & Company Profile powered by AI
The Sustainability assessment for Suzhou Zelgen Biopharmaceuticals Co Ltd indicates the company's reporting of the UN Sustainable Development Goals. Other corporations in the scoring peer group for Suzhou Zelgen Biopharmaceuticals Co Ltd are displayed below. If you are employed by Suzhou Zelgen Biopharmaceuticals Co Ltd and you would like to use your Sustainability aseessment, please contact us.
Suzhou Zelgen Biopharmaceuticals Co Ltd in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 0.0; made up of an environmental score of 0.0, social score of 0.0 and governance score of 0.0.
0.0
Low ImpactEnvironmental
Social
Governance

Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | Caladrius Biosciences Inc | 8.0 | High |
1 | Can Fite Biopharma Ltd | 8.0 | High |
... | ... | ... | |
1967 | Hospira Inc | 0.3 | Low |
1967 | PRA Health Sciences Inc | 0.3 | Low |
1970 | Suzhou Zelgen Biopharmaceuticals Co Ltd | 0.0 | Low |
1970 | CSPC Innovation Pharmaceutical Co Ltd | 0.0 | Low |
1970 | CTC Bio Inc | 0.0 | Low |
1970 | Zyden Gentec Ltd | 0.0 | Low |
1970 | iNtRON Biotechnology Inc | 0.0 | Low |
... | ... | ... |

Frequently Asked Questions
Does Suzhou Zelgen Biopharmaceuticals Co Ltd have an accelerator or VC vehicle to help deliver innovation?
Does Suzhou Zelgen Biopharmaceuticals Co Ltd disclose current and historical energy intensity?
Does Suzhou Zelgen Biopharmaceuticals Co Ltd report the average age of the workforce?
Does Suzhou Zelgen Biopharmaceuticals Co Ltd reference operational or capital allocation in relation to climate change?
Does Suzhou Zelgen Biopharmaceuticals Co Ltd disclose its ethnicity pay gap?
Does Suzhou Zelgen Biopharmaceuticals Co Ltd disclose cybersecurity risks?
Does Suzhou Zelgen Biopharmaceuticals Co Ltd offer flexible work?
Does Suzhou Zelgen Biopharmaceuticals Co Ltd have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Does Suzhou Zelgen Biopharmaceuticals Co Ltd disclose the number of employees in R&D functions?
Does Suzhou Zelgen Biopharmaceuticals Co Ltd conduct supply chain audits?
Does Suzhou Zelgen Biopharmaceuticals Co Ltd disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Does Suzhou Zelgen Biopharmaceuticals Co Ltd conduct 360 degree staff reviews?
Does Suzhou Zelgen Biopharmaceuticals Co Ltd disclose the individual responsible for D&I?
Does Suzhou Zelgen Biopharmaceuticals Co Ltd disclose current and historical air emissions?
Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Is executive remuneration linked to climate performance?
Does the Board describe its role in the oversight of climate-related risks and opportunities?
Does Suzhou Zelgen Biopharmaceuticals Co Ltd disclose current and / or historical scope 2 emissions?
Does Suzhou Zelgen Biopharmaceuticals Co Ltd disclose water use targets?
Does Suzhou Zelgen Biopharmaceuticals Co Ltd have careers partnerships with academic institutions?
Did Suzhou Zelgen Biopharmaceuticals Co Ltd have a product recall in the last two years?
Does Suzhou Zelgen Biopharmaceuticals Co Ltd disclose incidents of discrimination?
Does Suzhou Zelgen Biopharmaceuticals Co Ltd allow for Work Councils/Collective Agreements to be formed?
Has Suzhou Zelgen Biopharmaceuticals Co Ltd issued a profit warning in the past 24 months?
Does Suzhou Zelgen Biopharmaceuticals Co Ltd disclose parental leave metrics?
Does Suzhou Zelgen Biopharmaceuticals Co Ltd disclose climate scenario or pathway analysis?
Does Suzhou Zelgen Biopharmaceuticals Co Ltd disclose current and / or historical scope 1 emissions?
Are Operating Expesnses linked to emissions reduction?
Does Suzhou Zelgen Biopharmaceuticals Co Ltd disclose the pay ratio of women to men?
Does Suzhou Zelgen Biopharmaceuticals Co Ltd support suppliers with sustainability related research and development?
Does Suzhou Zelgen Biopharmaceuticals Co Ltd disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Does Suzhou Zelgen Biopharmaceuticals Co Ltd reflect climate-related risks in its financial statements?
Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Is Suzhou Zelgen Biopharmaceuticals Co Ltd involved in embryonic stem cell research?
Does Suzhou Zelgen Biopharmaceuticals Co Ltd disclose GHG and Air Emissions intensity?
Does Suzhou Zelgen Biopharmaceuticals Co Ltd disclose its waste policy?
Does Suzhou Zelgen Biopharmaceuticals Co Ltd report according to TCFD requirements?
Does Suzhou Zelgen Biopharmaceuticals Co Ltd disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Does Suzhou Zelgen Biopharmaceuticals Co Ltd disclose energy use targets?
Does Suzhou Zelgen Biopharmaceuticals Co Ltd disclose its Renewable Energy targets?

Are emissions metrics verified by STBi?

Does Suzhou Zelgen Biopharmaceuticals Co Ltd have a policy relating to cyber security?
Have a different question?
Potential Risks for Suzhou Zelgen Biopharmaceuticals Co Ltd
These potential risks are based on the size, segment and geographies of the company.
Suzhou Zelgen Biopharmaceuticals Co., Ltd. researches and develops, manufactures, and sells medicines in the People's Republic of China. It offers small molecule and recombinant protein drugs for the treatment of liver cancer, non-small cell lung cancer, colorectal cancer, thyroid cancer, nasopharyngeal carcinomas, myelofibrosis, hemorrhage, and hepatobiliary diseases. The company was founded in 2009 and is based in Kunshan, the People's Republic of China.